RAMOS
文献支持

RAMOS

收藏
  • ¥1480
  • EK-Bioscience已认证
  • CA-Y1430
  • 2025年07月14日
    avatar
    品牌商
    11钻石会员
  • 企业认证

    点击 QQ 联系

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 文献和实验
    • 技术资料
    • 规格

      T25

    Ramos/Ramos细胞系/Ramos细胞株/Ramos人B淋巴细胞瘤伯基特淋巴瘤细胞

    Cell line name Ramos

    Synonyms RAMOS; Ramos 1; RA 1; RA.1; Ra #1; Ra No. 1; Ramos(RA1); Ramos-RA1; Ramos (RA 1); Ramos (RA #1); Ramos (RA)

    Accession CVCL_0597

    Resource Identification Initiative To cite this cell line use: Ramos (RRID:CVCL_0597)

    Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).

    Part of: LL-100 blood cancer cell line panel.

    Part of: MD Anderson Cell Lines Project.

    Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.

    Population: Caucasian.

    Virology: EBV-negative.

    Doubling time: 20.4 +- 1.5 hours (PubMed=9225077); 23 hours (PubMed=8402660); 14 hours (PubMed=20922763); ~48 hours (DSMZ=ACC-603).

    Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).

    Omics: Deep exome analysis.

    Omics: Deep proteome analysis.

    Omics: Protein expression by reverse-phase protein arrays.

    Omics: SNP array analysis.

    Omics: Transcriptome analysis by microarray.

    Omics: Transcriptome analysis by RNAseq.

    Derived from site: In situ; Ascites; UBERON=UBERON_0007795.

    Cell type: B-cell; CL=CL_0000236.

    PubMed=12967475; DOI=10.1111/j.1349-7006.2003.tb01518.x; PMCID=PMC11160262

    Maesako Y., Uchiyama T., Ohno H.

    Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt's lymphoma and de novo diffuse large B-cell lymphoma.

    Cancer Sci. 94:774-781(2003)

     

    PubMed=18211290; DOI=10.1111/j.1365-2184.2007.00500.x; PMCID=PMC6495949

    Zander Balderud L., Bemark M.

    Identification of genes deregulated during serum-free medium adaptation of a Burkitt's lymphoma cell line.

    Cell Prolif. 41:136-155(2008)

     

    PubMed=20922763; DOI=10.1002/pbc.22801; PMCID=PMC3005554

    Kang M.H., Smith M.A., Morton C.L., Keshelava N., Houghton P.J., Reynolds C.P.

    National Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testing.

    Pediatr. Blood Cancer 56:239-249(2011)

     

    PubMed=22885699; DOI=10.1038/nature11378; PMCID=PMC3609867

    Schmitz R., Young R.M., Ceribelli M., Jhavar S., Xiao W.-M., Zhang M.-L., Wright G., Shaffer A.L. 3rd, Hodson D.J., Buras E., Liu X.-L., Powell J.I., Yang Y.-D., Xu W.-H., Zhao H., Kohlhammer H., Rosenwald A., Kluin P.M., Muller-Hermelink H.-K., Ott G., Gascoyne R.D., Connors J.M., Rimsza L.M., Campo E., Jaffe E.S., Delabie J., Smeland E.B., Ogwang M.D., Reynolds S.J., Fisher R.I., Braziel R.M., Tubbs R.R., Cook J.R., Weisenburger D.D., Chan W.-C., Pittaluga S., Wilson W., Waldmann T.A., Rowe M., Mbulaiteye S.M., Rickinson A.B., Staudt L.M.

    Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.

    Nature 490:116-120(2012)

     

    PubMed=24590883; DOI=10.1002/gcc.22161

    Murga Penas E.-M., Schilling G., Behrmann P., Klokow M., Vettorazzi E., Bokemeyer C., Dierlamm J.

    Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples.

    Genes Chromosomes Cancer 53:497-515(2014)

     

    PubMed=25960936; DOI=10.4161/21624011.2014.954893; PMCID=PMC4355981

    Boegel S., Lower M., Bukur T., Sahin U., Castle J.C.

    A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines.

    OncoImmunology 3:e954893.1-e954893.12(2014)

     

    PubMed=25485619; DOI=10.1038/nbt.3080

    Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z.-S., Liu H.-B., Degenhardt J., Mayba O., Gnad F., Liu J.-F., Pau G., Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M.-M., Zynda G.J., Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L., Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J., Settleman J., Seshagiri S., Zhang Z.-M.

    A comprehensive transcriptional portrait of human cancer cell lines.

    Nat. Biotechnol. 33:306-312(2015)

     

    PubMed=25877200; DOI=10.1038/nature14397

    Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M., Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S., Neve R.M.

    A resource for cell line authentication, annotation and quality control.

    Nature 520:307-311(2015)

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    *发表【中文论文】请标注:由上海酶研生物科技有限公司提供;

    *发表【英文论文】请标注:From Shanghai EK-Bioscience Biotechnology Co., Ltd.

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1400
    上海盖宁生物科技有限公司
    2025年12月04日询价
    ¥900
    安元生物科技(南京)有限公司
    2025年07月13日询价
    ¥600
    上海信裕生物科技有限公司
    2025年07月14日询价
    ¥1320
    博辉生物科技(广州)有限公司
    2025年12月05日询价
    ¥600
    上海再康生物科技有限公司
    2025年11月21日询价
    文献支持
    RAMOS
    ¥1480